Tailoring Lupus Nephritis Treatment: Key Considerations and Specialist Approaches

Author(s):

Ryan Haumschild, PharmD, MS, MBA,Jorge Larranaga, MD

Key Takeaways

Drug interactions, patient characteristics, and steroid use are critical in LN management, influencing treatment choices and outcomes.
Nephrologists focus on renal preservation, while rheumatologists emphasize controlling systemic lupus erythematosus, leading to differing treatment approaches.
Collaboration between nephrologists and rheumatologists is essential for optimizing LN patient outcomes and tailoring individualized treatment plans.

Panelists discuss the considerations guiding treatment choices for lupus nephritis, such as drug interactions, patient characteristics, and steroid use, and how treatment approaches might differ between nephrologists and rheumatologists.

EP: 1.Understanding the Clinical Burden and Prevalence of Lupus Nephritis

EP: 2.Cost Drivers in Lupus Nephritis

EP: 3.Urgency to Treat in Lupus Nephritis: Goals of Therapy and Early Diagnosis Strategies

EP: 4.Guideline Updates in Lupus Nephritis: Impacts on Clinical Decision-Making

Now Viewing

EP: 5.Tailoring Lupus Nephritis Treatment: Key Considerations and Specialist Approaches

EP: 6.Belimumab and Voclosporin: Clinical Insights and Payer Evaluations in Lupus Nephritis

EP: 7.Improving Access to Lupus Nephritis Treatment: Strategies and Resources

EP: 8.Lupus Nephritis Management: Monitoring Strategies and Long-Term Study Results

EP: 9.Collaborating for Better Care: Healthcare Providers and Payers in Lupus Nephritis

EP: 10.From Guidelines to Practice: Advancing Lupus Nephritis Treatment

EP: 11.Looking Ahead: Anticipating Changes in Lupus Guidelines and Clinical Practice

What considerations (eg, drug interactions, individual patient characteristics, steroid use) guide your treatment choices for managing lupus nephritis (LN)?

How might treatment approaches for LN differ between nephrologists and rheumatologists?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!